In response to the growing diabetes epidemic and increasing demand for insulin around the world, pharmaceutical company Eli Lilly and Co. announced Thursday it will invest more than $700 million to enhance its insulin manufacturing ...
Shooting down reports circulated Tuesday saying it planned to close its Guayama operation, pharmaceutical company Lilly del Caribe announced and launched a voluntary severance program for eligible employees working at the site.